FDA
-
-
-
-
-
-
-
Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment
-
-
-
-
-
-
-
Achieve Life Sciences raises $180 million in private placement, with up to additional $174 million from warrants
-
-
-
-
-
-
-
Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Hunterbrook Capital takes long position in Achieve Life Sciences ahead of FDA decision
-
-
-
-
-
-
-
Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation
-
-
-
-
-
-
-
Achieve Life Sciences publishes COPD smoking cessation data in Thorax
-
-
-
-
-
-
-
Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation
-
323,754 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

